Pages that link to "Q34613449"
Jump to navigation
Jump to search
The following pages link to Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis (Q34613449):
Displaying 50 items.
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America (Q22242935) (← links)
- Chronic Lyme disease: a review (Q22252200) (← links)
- Lyme disease: A rigorous review of diagnostic criteria and treatment (Q22252398) (← links)
- Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin (Q24675848) (← links)
- Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi (Q24677545) (← links)
- An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole (Q28137907) (← links)
- A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated (Q28292075) (← links)
- Systematic review of the treatment of early Lyme disease (Q33585350) (← links)
- Ineffectiveness of tigecycline against persistent Borrelia burgdorferi (Q33613691) (← links)
- Management of Lyme arthritis (Q33647324) (← links)
- In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy (Q33722062) (← links)
- Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections (Q34142328) (← links)
- Chronic Lyme disease: the controversies and the science (Q34205531) (← links)
- Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease (Q34336214) (← links)
- Review of treatment options for lyme borreliosis (Q34471224) (← links)
- Lyme neuroborreliosis-epidemiology, diagnosis and management (Q34487119) (← links)
- Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease. (Q34761872) (← links)
- Treatment of tick-borne diseases (Q34874402) (← links)
- Lyme disease: the next decade (Q35026635) (← links)
- Lyme disease: a growing threat to urban populations (Q35110893) (← links)
- Diagnosis, treatment, and prevention of Lyme disease in children (Q35135371) (← links)
- Current recommendations for the treatment of Lyme disease (Q35329131) (← links)
- Lyme disease in paediatrics (Q35627026) (← links)
- Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review (Q35658597) (← links)
- Neuroborreliosis: the Guillain-Barré mimicker (Q35808450) (← links)
- Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges (Q35817227) (← links)
- Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know (Q36679488) (← links)
- Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures (Q36948131) (← links)
- Use of third-generation cephalosporins. Spirochetes (Q37381384) (← links)
- Controversies in Persistent (Chronic) Lyme Disease (Q37403994) (← links)
- Spirochetal infections (Q37683108) (← links)
- Antibiotics for the neurological complications of Lyme disease (Q39032987) (← links)
- Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. (Q39781985) (← links)
- Third-generation cephalosporins (Q40550719) (← links)
- In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics (Q40674670) (← links)
- Efficacy of antibiotic prophylaxis for prevention of Lyme disease (Q41109026) (← links)
- Lyme neuroborreliosis in children (Q41114759) (← links)
- Prevalence of antibodies to tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in samples from patients with abnormalities in the cerebrospinal fluid. (Q42990770) (← links)
- Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis (Q43451624) (← links)
- Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis (Q43573213) (← links)
- Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America (Q44628961) (← links)
- Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone (Q44981549) (← links)
- The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic (Q50041916) (← links)
- Cost Effectiveness of Oral as Compared with Intravenous Antibiotic Therapy for Patients with Early Lyme Disease or Lyme Arthritis (Q53592534) (← links)
- Therapy of Lyme borreliosis in children. (Q53990849) (← links)
- Lyme disease: clinical diagnosis and treatment. (Q55284263) (← links)
- Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters (Q64053858) (← links)
- Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis (Q71643428) (← links)
- Neuroborreliosis (Q72180540) (← links)
- Lyme borreliosis (Q72369253) (← links)